Gozde Colak, Ph.D.

Affiliations: 
2011 School of Medicine and Dentistry University of Rochester, Rochester, NY 
Area:
Neuroscience Biology, Cell Biology
Google:
"Gozde Colak"
Mean distance: 53433
 

Parents

Sign in to add mentor
Gail V. W Johnson grad student 2011 Rochester
 (The Role of Transglutaminase 2 in Ischemic Cell Death.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Eckert RL, Kaartinen MT, Nurminskaya M, et al. (2014) Transglutaminase regulation of cell function. Physiological Reviews. 94: 383-417
Gundemir S, Colak G, Feola J, et al. (2013) Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization. Biochimica Et Biophysica Acta. 1833: 1-10
Johnson KB, Petersen-Jones H, Thompson JM, et al. (2012) Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. American Journal of Physiology. Heart and Circulatory Physiology. 302: H1355-66
Colak G, Johnson GV. (2012) Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia. Neurobiology of Disease. 45: 1042-50
Gundemir S, Colak G, Tucholski J, et al. (2012) Transglutaminase 2: a molecular Swiss army knife. Biochimica Et Biophysica Acta. 1823: 406-19
Colak G, Filiano AJ, Johnson GV. (2011) The application of permanent middle cerebral artery ligation in the mouse. Journal of Visualized Experiments : Jove
Colak G, Keillor JW, Johnson GV. (2011) Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation. Plos One. 6: e16665
Filiano AJ, Tucholski J, Dolan PJ, et al. (2010) Transglutaminase 2 protects against ischemic stroke. Neurobiology of Disease. 39: 334-43
See more...